Merck (LIM:MRK) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


LIM:MRK Merck & Co Inc LIM:MRK
71 GF Score
Price $120.00
GF Value $117.83
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Merck Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Merck's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

LIM:MRK vs ABBV, AMGN, GILD: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - General subindustry, Merck's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Merck Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Merck's Margin of Safety % (DCF Earnings Based) falls into.


LIM:MRK
71GF Score
Merck & Co Inc LIM:MRK
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck (LIM:MRK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of $120.00 is trading 1.8% above its estimated GF Value™ of $117.83. GuruFocus considers Merck to be Fairly Valued.

Key valuation signals for LIM:MRK:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $117.83 vs. price of $120.00 (1.8% above fair value)
  • GF Score™: 71/100 with 7 warning signs

No single metric tells the full story. See the LIM:MRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
71GF Score

Get the complete analysis for LIM:MRK

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$120.00
Price
$117.83
GF Value